Logo image of AAQ1.DE

AAP IMPLANTATE (AAQ1.DE) Stock Fundamental Analysis

FRA:AAQ1 - DE000A3H2101 - Common Stock

1.65 EUR
-0.01 (-0.6%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AAQ1. AAQ1 was compared to 57 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of AAQ1 have multiple concerns. AAQ1 is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AAQ1 has reported negative net income.
In the past 5 years AAQ1 always reported negative net income.
In the past 5 years AAQ1 always reported negative operating cash flow.
AAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFAAQ1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M

1.2 Ratios

AAQ1's Return On Assets of -18.80% is on the low side compared to the rest of the industry. AAQ1 is outperformed by 70.18% of its industry peers.
AAQ1's Return On Equity of -29.40% is on the low side compared to the rest of the industry. AAQ1 is outperformed by 70.18% of its industry peers.
Industry RankSector Rank
ROA -18.8%
ROE -29.4%
ROIC N/A
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
AAQ1.DE Yearly ROA, ROE, ROICAAQ1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 -40 -60 -80 -100

1.3 Margins

Looking at the Gross Margin, with a value of 87.45%, AAQ1 belongs to the top of the industry, outperforming 94.74% of the companies in the same industry.
AAQ1's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for AAQ1 so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 87.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
AAQ1.DE Yearly Profit, Operating, Gross MarginsAAQ1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100

More info and screens

3

2. Health

2.1 Basic Checks

AAQ1 does not have a ROIC to compare to the WACC, probably because it is not profitable.
AAQ1 has more shares outstanding than it did 1 year ago.
AAQ1 has more shares outstanding than it did 5 years ago.
AAQ1 has a better debt/assets ratio than last year.
AAQ1.DE Yearly Shares OutstandingAAQ1.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
AAQ1.DE Yearly Total Debt VS Total AssetsAAQ1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

AAQ1 has an Altman-Z score of 0.58. This is a bad value and indicates that AAQ1 is not financially healthy and even has some risk of bankruptcy.
AAQ1's Altman-Z score of 0.58 is on the low side compared to the rest of the industry. AAQ1 is outperformed by 70.18% of its industry peers.
A Debt/Equity ratio of 0.17 indicates that AAQ1 is not too dependend on debt financing.
The Debt to Equity ratio of AAQ1 (0.17) is better than 73.68% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Altman-Z 0.58
ROIC/WACCN/A
WACC6.95%
AAQ1.DE Yearly LT Debt VS Equity VS FCFAAQ1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M

2.3 Liquidity

AAQ1 has a Current Ratio of 2.12. This indicates that AAQ1 is financially healthy and has no problem in meeting its short term obligations.
AAQ1 has a better Current ratio (2.12) than 63.16% of its industry peers.
A Quick Ratio of 1.03 indicates that AAQ1 should not have too much problems paying its short term obligations.
AAQ1's Quick ratio of 1.03 is in line compared to the rest of the industry. AAQ1 outperforms 45.61% of its industry peers.
Industry RankSector Rank
Current Ratio 2.12
Quick Ratio 1.03
AAQ1.DE Yearly Current Assets VS Current LiabilitesAAQ1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 68.18% over the past year.
The Revenue has been growing slightly by 6.32% in the past year.
AAQ1 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.78% yearly.
EPS 1Y (TTM)68.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
Based on estimates for the next years, AAQ1 will show a quite strong growth in Revenue. The Revenue will grow by 11.66% on average per year.
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AAQ1.DE Yearly Revenue VS EstimatesAAQ1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 10M 20M 30M
AAQ1.DE Yearly EPS VS EstimatesAAQ1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -1 -2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

AAQ1 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AAQ1 is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AAQ1.DE Price Earnings VS Forward Price EarningsAAQ1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AAQ1.DE Per share dataAAQ1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AAQ1 does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AAP IMPLANTATE

FRA:AAQ1 (9/5/2025, 7:00:00 PM)

1.65

-0.01 (-0.6%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-18 2025-08-18
Earnings (Next)N/A N/A
Inst Owners17.2%
Inst Owner ChangeN/A
Ins Owners10.14%
Ins Owner ChangeN/A
Market Cap22.95M
Analysts42.22
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.88
P/FCF N/A
P/OCF N/A
P/B 1.86
P/tB 2.2
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.07
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0.88
BVpS0.89
TBVpS0.75
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -18.8%
ROE -29.4%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 87.45%
FCFM N/A
ROA(3y)-27.22%
ROA(5y)-27.6%
ROE(3y)-50.99%
ROE(5y)-51.91%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.81%
GM growth 5Y-0.65%
F-ScoreN/A
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.17
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.12
Quick Ratio 1.03
Altman-Z 0.58
F-ScoreN/A
WACC6.95%
ROIC/WACCN/A
Cap/Depr(3y)23.96%
Cap/Depr(5y)22.7%
Cap/Sales(3y)3.48%
Cap/Sales(5y)3.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)68.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y65%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.32%
Revenue growth 3Y0.1%
Revenue growth 5Y0.78%
Sales Q2Q%N/A
Revenue Next Year15.38%
Revenue Next 2Y22.14%
Revenue Next 3Y12.95%
Revenue Next 5Y11.66%
EBIT growth 1Y63.22%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year173.33%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y57.21%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y62.43%
OCF growth 3YN/A
OCF growth 5YN/A